Industry News

medical marijuana, but the new law should have little impact on Springfield employers, a local expert said Tuesday. The state's new law legalizing medical marijuana took affect in September, although it will likely be one to two years before patients can legally use the drug. Once up and running, the law could affect as many as 200,000 Ohioans and have an economic impact of $300 million to $400 million per year,..."/>
Marijuana law likely to have little impact on Springfield employers [Springfield News-Sun, Ohio]
Quality Systems, Inc. will release its fiscal 2017 second quarter operating results on Thursday, October 27, 2016 before the market opens, with a conference call to follow at 8:30 a.m. Eastern Time. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 866-900-9499 or 937-502-2136 for international callers, and referencing participant code 95129126 approximately 15 minutes prior to the call."/>
Quality Systems, Inc. to Host Fiscal 2017 Second Quarter Results Conference Call
Exactech Innovations Presented at International Scientific Conference. GAINESVILLE, Fla.---- Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and its ExactechGPS ® guided personalized surgery system were featured at the 29th Congress of The International Society for Technology in Arthroplasty in Boston,..."/>
New Studies Support Exactech’s Knee, Shoulder and Computer-Assisted Surgery Technologies
Cerner Corp. has chosen an official address for its new Innovations campus under construction in south Kansas City and has named roadways on the property between 87th and 95th streets. The property is part of a 10- year, $4.45 billion plan, the largest such development under way in Missouri. The campus is designed to include 16 buildings eventually and may house as many as 16,000 workers, according to company projections."/>
Cerner names roads in its new south Kansas City office campus [The Kansas City Star]
Humana Inc., one of the nation’ s leading health benefits companies, announced today that it has launched a series of disaster relief efforts assisting its associates, members and communities impacted by Hurricane Matthew. Humana Southeast Regional Medicare President Jim Laughlin, said,“ We..."/>
Humana Offers Support to Communities Impacted by Hurricane Matthew
Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider with a unique, promising therapeutic development pipeline, announces today the appointment of Gregory R. Brown, MD, to its Board of Directors. Brown will serve as Chairman of the Audit Committee and a member of the..."/>
Caladrius Biosciences Appoints Gregory R. Brown, MD, to its Board of Directors
INC Research Holdings, Inc., a leading, global Phase I to IV contract research organization, today announced its extensive participation in the Society for Clinical Research Sites' 11 th Annual Global Site Solutions Summit Oct. 13-16 in Boca Raton, Fla. INC Research thought leaders will participate in seven sessions to discuss issues that impact the way sites conduct research and recruit patients, while offering strategies to improve collaboration..."/>
INC Research Demonstrates Ongoing Commitment to Clinical Research Sites at SCRS 2016 Global Site Solutions Summit
Envision Healthcare Holdings, Inc. and Tennessee-based ambulatory and physician services company Amsurg Corp. have announced the composition of the board of directors of the newly formed Envision Healthcare Corp. following completion of their merger, the companies said. In addition, both companies will hold their separate special meetings of shareholders on Monday, November 28, 2016 to..."/>
Envision Healthcare, Ambulatory, Physician Services Firm Amsurg Name Post-Merger Board
Aetna reported on Tuesday the launch of a value-based agreement with Merck to help adult patients with type 2 diabetes access appropriate treatment including Januvia and Janumet. As part of this agreement, Merck's rebates on Januvia and Janumet will be based in part on those products' contributions to helping Aetna's commercial member population with type 2 diabetes achieve or maintain treatment objectives. In conjunction with the agreement, Merck will..."/>
Aetna partners with Merck to help adult patients with type 2 diabetes get access to Januvia and Janumet
Neurocrine Biosciences Inc said on Tuesday that its New Drug Application for INGREZZAT has been accepted for Priority Review by the US Food and Drug Administration for the treatment of tardive dyskinesia. The company's INGREZZA application has been given a Prescription Drug User Fee Act target action date of 11 April 2017.. A Priority Review designation accelerates the FDA review timeline from ten months to six months from the date of acceptance of..."/>
Neurocrine Biosciences' NDA for INGREZZAT accepted for FDA Priority Review
Surgical Care Affiliates said on Tuesday that it plans to refinance its existing term loan facility, under which, USD444.4m is currently outstanding. Under the refinancing agreement, the company proposes to replace the existing term loan facility with a new USD444.4m term loan facility plus to obtain an incremental term loan of USD150m in aggregate principal amount. Proceeds from the new term loan facility are expected to be used by the company to..."/>
Surgical Care Affiliates enters into new financing agreements
IRIDEX announced on Tuesday its preliminary revenues in the range of USD9.6m to USD9.7m for the Q3 2016.. This marks a decline when compared with the higher previous revenue guidance in the USD11.0m to USD11.3m range. While demand for the company's new flagship Cyclo G6 laser platform for glaucoma remained strong, revenues of certain retina products were below expectations although it ended the third quarter with a record high in back orders."/>
IRIDEX updates lower Q3 2016 preliminary revenues in USD9.6m to USD9.7m range
Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2016 on Tuesday, October 25, 2016. The Company has scheduled a conference call for that same day, Tuesday, October 25, 2016 at 11:00am ET to discuss the results of the quarter. Interested parties can access the call by dialing:."/>
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2016 Financial Results
Scientific Industries Inc. reported net income of $165,600 on net sales of $9,597,600, for the fiscal year ended June 30, 2016, compared to $8,700 on net sales of $7,848,400 for the fiscal year ended June 30, 2015.. The increased income and revenues resulted primarily from increased sales and profits due to a substantial order for catalyst research instruments in fiscal 2016, and lower operating expenses of the Company’ s benchtop laboratory..."/>
Scientific Industries Reports Improved Results for Fiscal 2016
Humana’ s focus on quality care for its Medicare members Demonstrated success of the company’ s integrated care delivery model is indicative of quality outcomes for the company’ s members Average HEDIS quality score at record high Most recent Star ratings not anticipated to materially impact Medicare membership growth for 2017 Company expects to take certain measures to mitigate potential negative impact on 2018 Star bonus..."/>
Humana Comments on Medicare Star Quality Ratings and Raises 2016 Financial Guidance
Brookdale Senior Living Inc. announced today that Cedric T. Coco has been named Executive Vice President and Chief People Officer. Cedric joins the Company after serving in various human resource roles for Lowe's Companies, Inc. since 2008, most recently as senior vice president of human resources, where he led the human resources generalists for Lowe's stores, distribution centers and customer support centers, in addition to leading..."/>
Brookdale Senior Living names Cedric T. Coco as EVP and Chief People Officer
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended September 30, 2016 after the market closes on Tuesday, October 25, 2016, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial 407-8037 or 689-8037. For 72 hours..."/>
Edwards Lifesciences To Host Earnings Conference Call On October 25, 2016
Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, will visit the Nasdaq MarketSite in Times Square, in celebration of its recently closed $30 million financing. In honor of the occasion, Adam Gridley, President and Chief Executive Officer, will ring the Closing Bell. Where: Nasdaq MarketSite– 4 Times Square– 43 rd& Broadway– Broadcast Studio."/>
Histogenics Corporation (Nasdaq: HSGX), to Ring The Nasdaq Stock Market Closing Bell
Teva Pharmaceutical Industries Ltd., today announced the launch of RAJANI TM in the United States. RAJANI TM, the generic equivalent of Beyaz ® 1, is an oral contraceptive, available in a 28- day blister pack dispenser, for use by women to:. prevent pregnancy; treat symptoms of premenstrual dysphoric disorder in women choosing to use an oral contraceptive for contraception; treat moderate acne for women at least 14 years old if the patient desires an oral contraceptive..."/>
Teva Announces Launch of Generic Beyaz® in the United States
LifePoint Health system that have enrolled in the LifePoint National Quality Program and succeeded in transforming their culture of safety and achieving high standards of quality care, performance..."/>
Clinch Valley Medical Center Named Duke LifePoint Quality Affiliate
Spotlight Innovation Inc. today announced that the Company will present at the Fall SeeThruEquity Microcap Investor Conference being held at Convene Grand Central located at 101 Park Avenue in New York City on October 17, 2016.. During Spotlight Innovation's 30- minute presentation, which begins at 10:30 a.m. ET, management will provide an overview of Company activities to an audience of investors and industry professionals."/>
Spotlight Innovation to Present at the Fall SeeThruEquity Microcap Investor Conference in New York City on October 17, 2016
Aethlon Medical, Inc., announced today that Jim Joyce, Chairman and CEO, will be presenting a corporate update at the 2016 Bio Investor Forum in San Francisco, CA at 6:30 p.m. ET on Tuesday, October 18, 2016.. The presentation will be made available to the public via live audio webcast which can be accessed by visiting the investor relations section of Aethlon Medical's corporate website at The webcast will be..."/>
Aethlon Medical Announces Corporate Update Presentation At Next Week's 2016 Bio Investor Forum

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology571 Articles
Consumer Discretionary538 Articles
Financials490 Articles
Health Care340 Articles
Industrials325 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at